Skip to content

Optimization of Interval-training in Patients With Type 2 Diabetes

Optimization of Interval-training in Patients With Type 2 Diabetes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02601482
Enrollment
14
Registered
2015-11-10
Start date
2015-10-31
Completion date
2016-10-31
Last updated
2016-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

Glycemic control, exercise, Interval Training

Brief summary

A single bout of Interval-Walking (IW) exercise is superior to energy-expenditure and time-duration matched Continuous Walking (CW) exercise upon improving glycemic control. The time spend with high-intensity (fast) walking is considered to be responsible for the improvements seen, whereas the time spend with low-intensity (slow) walking is considered less important. This study will assess if IW with maintained fast walking time duration but reduced total time duration (i.e. reduced slow walking time duration) is equally effective as IW with a normal time duration. Subjects with type 2 diabetes will be included in a crossover, controlled study, where each subject will undergo three trials. Trials will be identical except the following interventions: 1. Sixty minutes of rest (CON) 2. Sixty minutes of classical interval walking (repeated cycles of 3 minutes of fast and 3 minutes of slow walking; IW-60) 3. Fourty-five minutes of time-reduced interval walking (repeated cycles of 3 minutes of fast and 1.5 minutes of slow walking; IW-45). After the interventions subjects will undergo a standardized mixed meal tolerance test with assessment of glycemic control.

Interventions

BEHAVIORALCON
BEHAVIORALIW-60
BEHAVIORALIW-45

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Type 2 Diabetes Mellitus * BMI \> 25

Exclusion criteria

* Pregnancy * Smoking * Contraindication to increased levels of physical activity * Eating disorder * Insulin dependence

Design outcomes

Primary

MeasureTime frameDescription
Glycemic controlWithin the first 4 hours after the interventionGlycemic control will be assessed after each intervention. Subjects will receive a standardized mixed meal tolerance test (MMTT), and blood glucose values will be obtained during the test.

Secondary

MeasureTime frameDescription
Matsuda insulin sensitivity indexWithin the first 4 hours after the interventionFrom the measurements of glucose and insulin during the MMTT, the Matsuda index of insulin sensitivity will be assessed.
Stumvoll insulin sensitivity indexWithin the first 4 hours after the interventionFrom the measurements of glucose and insulin during the MMTT, the Stumvoll index of insulin sensitivity will be assessed.
Cederholm insulin sensitivity indexWithin the first 4 hours after the interventionFrom the measurements of glucose and insulin during the MMTT, the Cederholm index of insulin sensitivity will be assessed.
HOMA-2 insulin resistance indexWithin the first 4 hours after the interventionFrom the measurements of glucose and insulin during the MMTT, the HOMA-2 index of insulin resistance will be assessed.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026